SOFIA (Bulgaria), December 4 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Monday its sales revenue rose by an annual 12% in the 11 months through November, as exports increased by 21%.
On the domestic market, the company’s sales fell 1% year-on-year in January-November, Sopharma said in a bourse filing without providing figures of the value of its sales.
In November alone, Sopharma’s sales revenue rose 11% year-on-year.
Sopharma, Bulgaria's biggest pharmaceuticals producer, has subsidiaries in Moldova, Russia, Serbia, Belarus, Poland, Latvia, Lithuania, Ukraine and Kazakhstan.
In April, Sopharma acquired a 51% stake in Moldova’s drug distributor RAP Pharma International for an undisclosed price.
As at 1305 CET on Monday, Sopharma shares traded 0.33% higher at 4.294 levs ($2.6/2.2 euro).
(1 euro=1.95583 levs)